drugset / Trial / NCT07402915

Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT07402915

Phase 1 Recruiting 24 enrolled AstraZeneca
Non-randomizedSequentialOpen-labelTreatment

Summary

The purpose of this study is to assess the effect of itraconazole on the pharmacokinetics (PK) of AZ14170132.

Timeline

Start
2026-01-26
Primary completion
2027-10-15
Completion
2027-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD5335 Unknown Intravenous
Subject Itraconazole Small molecule Oral